Exothera vs Thermo Fisher Scientific: CDMO Comparison
How does Exothera compare to Thermo Fisher Scientific?
As of Mar 2026, Exothera: no FDA inspections on file, 4 EMA/MHRA GMP certificates. Signal Score 78.1. Thermo Fisher Scientific: 19 FDA inspections (including 6 NAI, 13 VAI and 0 OAI), 10 EMA/MHRA GMP certificates. Signal Score 77.6. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of Exothera and Thermo Fisher Scientific on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Thermo Fisher Scientific has more FDA inspections on record (19 vs 0) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Exothera has materially broader EMA GMP coverage (4 active certificates vs 1) — stronger EU footprint.
- Thermo Fisher Scientific maintains 9 MHRA / UK GMP certificates; Exothera does not.
Across the cross-modality scorecard, Exothera carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.
Frequently asked: Exothera vs Thermo Fisher Scientific
How does Exothera compare to Thermo Fisher Scientific?
On CDMO Signal's composite Signal Score, Exothera is 78/100 and Thermo Fisher Scientific is 78/100; Exothera has 0 FDA inspections on record vs 19 for Thermo Fisher Scientific; European coverage is 4 active EMA+MHRA certificates for Exothera vs 10 for Thermo Fisher Scientific. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Exothera or Thermo Fisher Scientific?
Both Exothera and Thermo Fisher Scientific maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Exothera has 0 FDA inspections on record; Thermo Fisher Scientific has 19.
How do Exothera and Thermo Fisher Scientific compare on European GMP coverage?
Exothera holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. Thermo Fisher Scientific holds 1 active EMA GMP certificate and 9 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — Exothera or Thermo Fisher Scientific?
Exothera is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Thermo Fisher Scientific is matched to 2. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
What does the Signal Score gap mean in practice?
Exothera carries a Signal Score of 78/100 and Thermo Fisher Scientific carries 78/100 — essentially tied for Exothera. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →